Global Fabry Disease Treatment Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

Table of Contents

1 Fabry Disease Treatment Market Overview

• 1.1 Product Overview and Scope of Fabry Disease Treatment
• 1.2 Classification of Fabry Disease Treatment by Types
  • 1.2.1 Global Fabry Disease Treatment Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Fabry Disease Treatment Revenue Market Share by Types in 2018
  • 1.2.3 Enzyme Replacement Therapy (ERT)
  • 1.2.4 Chaperone Treatment
  • 1.2.5 Substrate Reduction Therapy (SRT)
  • 1.2.6 Others
• 1.3 Global Fabry Disease Treatment Market by Application
  • 1.3.1 Global Fabry Disease Treatment Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Fabry Disease Treatment Market by Regions
  • 1.4.1 Global Fabry Disease Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Fabry Disease Treatment Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Fabry Disease Treatment Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Fabry Disease Treatment Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Fabry Disease Treatment Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Fabry Disease Treatment Status and Prospect (2014-2024)
• 1.5 Global Market Size of Fabry Disease Treatment (2014-2024)

2 Manufacturers Profiles

• 2.1 Sanofi S.A.
  • 2.1.1 Business Overview
  • 2.1.2 Fabry Disease Treatment Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Sanofi S.A. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Shire Plc.
  • 2.2.1 Business Overview
  • 2.2.2 Fabry Disease Treatment Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Shire Plc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Amicus Therapeutics Inc.
  • 2.3.1 Business Overview
  • 2.3.2 Fabry Disease Treatment Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 ISU Abxis Co Ltd.
  • 2.4.1 Business Overview
  • 2.4.2 Fabry Disease Treatment Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 JCR Pharmaceuticals Co Ltd.
  • 2.5.1 Business Overview
  • 2.5.2 Fabry Disease Treatment Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Protalix Biotherapeutics Inc.
  • 2.6.1 Business Overview
  • 2.6.2 Fabry Disease Treatment Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Idorsia Pharmaceuticals Ltd.
  • 2.7.1 Business Overview
  • 2.7.2 Fabry Disease Treatment Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Avrobio Inc.
  • 2.8.1 Business Overview
  • 2.8.2 Fabry Disease Treatment Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Avrobio Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Greenovation Biotech GmbH
  • 2.9.1 Business Overview
  • 2.9.2 Fabry Disease Treatment Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Moderna Therapeutics Inc.
  • 2.10.1 Business Overview
  • 2.10.2 Fabry Disease Treatment Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Green Cross Pharma Pte Ltd.
  • 2.11.1 Business Overview
  • 2.11.2 Fabry Disease Treatment Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Fabry Disease Treatment Market Competition, by Players

• 3.1 Global Fabry Disease Treatment Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Fabry Disease Treatment Players Market Share
  • 3.2.2 Top 10 Fabry Disease Treatment Players Market Share
• 3.3 Market Competition Trend

4 Global Fabry Disease Treatment Market Size by Regions

• 4.1 Global Fabry Disease Treatment Revenue and Market Share by Regions
• 4.2 North America Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 4.3 Europe Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 4.5 South America Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Fabry Disease Treatment Revenue and Growth Rate (2014-2019)

5 North America Fabry Disease Treatment Revenue by Countries

• 5.1 North America Fabry Disease Treatment Revenue by Countries (2014-2019)
• 5.2 USA Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 5.3 Canada Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Fabry Disease Treatment Revenue and Growth Rate (2014-2019)

6 Europe Fabry Disease Treatment Revenue by Countries

• 6.1 Europe Fabry Disease Treatment Revenue by Countries (2014-2019)
• 6.2 Germany Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 6.3 UK Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 6.4 France Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 6.5 Russia Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 6.6 Italy Fabry Disease Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Fabry Disease Treatment Revenue by Countries

• 7.1 Asia-Pacific Fabry Disease Treatment Revenue by Countries (2014-2019)
• 7.2 China Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 7.3 Japan Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 7.4 Korea Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 7.5 India Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Fabry Disease Treatment Revenue and Growth Rate (2014-2019)

8 South America Fabry Disease Treatment Revenue by Countries

• 8.1 South America Fabry Disease Treatment Revenue by Countries (2014-2019)
• 8.2 Brazil Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Fabry Disease Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Fabry Disease Treatment by Countries

• 9.1 Middle East and Africa Fabry Disease Treatment Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 9.3 UAE Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Fabry Disease Treatment Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Fabry Disease Treatment Revenue and Growth Rate (2014-2019)

10 Global Fabry Disease Treatment Market Segment by Type

• 10.1 Global Fabry Disease Treatment Revenue and Market Share by Type (2014-2019)
• 10.2 Global Fabry Disease Treatment Market Forecast by Type (2019-2024)
• 10.3 Enzyme Replacement Therapy (ERT) Revenue Growth Rate (2014-2024)
• 10.4 Chaperone Treatment Revenue Growth Rate (2014-2024)
• 10.5 Substrate Reduction Therapy (SRT) Revenue Growth Rate (2014-2024)
• 10.6 Others Revenue Growth Rate (2014-2024)

11 Global Fabry Disease Treatment Market Segment by Application

• 11.1 Global Fabry Disease Treatment Revenue Market Share by Application (2014-2019)
• 11.2 Fabry Disease Treatment Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Clinic Revenue Growth (2014-2019)
• 11.5 Others Revenue Growth (2014-2019)

12 Global Fabry Disease Treatment Market Size Forecast (2019-2024)

• 12.1 Global Fabry Disease Treatment Market Size Forecast (2019-2024)
• 12.2 Global Fabry Disease Treatment Market Forecast by Regions (2019-2024)
• 12.3 North America Fabry Disease Treatment Revenue Market Forecast (2019-2024)
• 12.4 Europe Fabry Disease Treatment Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Fabry Disease Treatment Revenue Market Forecast (2019-2024)
• 12.6 South America Fabry Disease Treatment Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Fabry Disease Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology